JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
A10 Networks
ATEN
$2.13B
| $2.64M | ﹤0.01% |
423,383
-201,791
| -32% | -$1.22M |
|
|
NPTN
2952
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.64M | ﹤0.01% |
407,696
+255,014
| +167% | +$1.95M |
|
2953
CALL
Baxter International
BAX
$13.5B
| $2.63M | ﹤0.01% |
40,000
+8,900
| +29% | +$598K |
|
2954
Constellium
CSTM
$3.76B
| $2.63M | ﹤0.01% |
375,730
+178,949
| +91% | +$1.59M |
|
|
ALDR
2955
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.63M | ﹤0.01% |
256,140
-14,232
| -5% | -$182K |
|
2956
AZZ Inc
AZZ
$4.35B
| $2.62M | ﹤0.01% |
64,991
+45,368
| +231% | +$2.05M |
|
2957
CALL
Fastenal
FAST
$54.7B
| $2.62M | ﹤0.01% |
200,000
| – | – |
|
|
KBAL
2958
DELISTED
Kimball International
KBAL
| $2.61M | ﹤0.01% |
184,017
-26,240
| -12% | -$411K |
|
2959
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $2.61M | ﹤0.01% |
32,088
+5,259
| +20% | +$421K |
|
2960
Emergent Biosolutions
EBS
$373M
| $2.61M | ﹤0.01% |
43,989
+17,210
| +64% | +$1.11M |
|
2961
CALL
Paychex
PAYX
$41.6B
| $2.61M | ﹤0.01% |
40,000
-96,700
| -71% | -$6.55M |
|
|
CALY
2962
Callaway Golf Company
CALY
$3.32B
| $2.6M | ﹤0.01% |
169,904
+5,796
| +4% | +$116K |
|
2963
INNOVATE Corp
VATE
$111M
| $2.6M | ﹤0.01% |
98,387
-50,473
| -34% | -$2.13M |
|
|
MRLN
2964
DELISTED
Marlin Business Services Corp
MRLN
| $2.59M | ﹤0.01% |
116,109
+5,380
| +5% | +$138K |
|
|
FONR
2965
DELISTED
Fonar
FONR
| $2.59M | ﹤0.01% |
128,052
+66,036
| +106% | +$1.49M |
|
2966
Glaukos
GKOS
$9.83B
| $2.59M | ﹤0.01% |
46,105
-44,583
| -49% | -$2.68M |
|
2967
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.59M | ﹤0.01% |
30,400
-19,600
| -39% | -$1.86M |
|
|
BOLD
2968
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.58M | ﹤0.01% |
121,152
+3,868
| +3% | +$99.8K |
|
2969
Turning Point Brands
TPB
$1.45B
| $2.58M | ﹤0.01% |
94,692
+12,624
| +15% | +$444K |
|
2970
PUT
Kroger
KR
$35.4B
| $2.57M | ﹤0.01% |
93,500
-82,100
| -47% | -$2.38M |
|
2971
FirstService
FSV
$6.48B
| $2.57M | ﹤0.01% |
37,536
-12,964
| -26% | -$969K |
|
2972
Northwest Bancshares
NWBI
$2.3B
| $2.57M | ﹤0.01% |
151,719
+80,427
| +113% | +$1.36M |
|
|
AXE
2973
DELISTED
Anixter International Inc
AXE
| $2.56M | ﹤0.01% |
47,196
+20,776
| +79% | +$1.31M |
|
|
ARRY
2974
DELISTED
Array Biopharma Inc
ARRY
| $2.56M | ﹤0.01% |
179,306
+6,096
| +4% | +$92.5K |
|
|
AGR
2975
DELISTED
Avangrid, Inc.
AGR
| $2.55M | ﹤0.01% |
50,841
+21,128
| +71% | +$1.04M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.